Loss of function mutations in the two-pore potassium channel, TRESK, linked to migraine


  • The two-pore potassium channel, TRESK, plays a key role in human nociceptor function and migraine mechanisms.

Why this matters

    These novel data support a genetic role of specific TRESK mutations in migraine; TRESK could represent a therapeutic target in migraine, with TRESK activators effective in blocking pain.

Want to read more?

Log in or sign up to access all Neurodiem content.

Already have an account? Log In

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.